![]() |
市场调查报告书
商品编码
1828098
2025年全球支气管镜市场报告Bronchoscope Global Market Report 2025 |
近年来,支气管镜市场呈现强劲成长势头,市场规模从2024年的29.5亿美元成长至2025年的32亿美元,复合年增长率达8.8%。预测期内的成长可归因于认知度和接受度的提升、医学训练和教育、临床应用和支气管内介入治疗的开展、对微创技术的需求以及人口老化。
预计未来几年支气管镜市场将快速成长,到2029年将达到49.7亿美元,复合年增长率为11.6%。预测期内的成长动力包括呼吸系统疾病的增加、人口老化、对微创手术的需求、机器人技术的进步以及对早期诊断的重视。预测期内的主要趋势包括小型化和便携性、对患者安全和舒适度的重视、扩增实境(AR) 和导航系统、远端医疗和远端引导以及一次性支气管镜。
支气管镜是用于目视检查肺部和气道的重要医疗设备。它由一根柔性或刚性的管子组成,管端装有摄影机和光源,方便医生观察气管、支气管和支气管导管。支气管镜既可用于诊断,也可用于治疗,有助于组织切片检查、去除异物以及各种气道医疗干预等操作。
支气管镜主要有两种类型:硬式和软式。硬式支气管镜由金属製成,由手柄、管和鞘套组成。它们用于诊断和治疗呼吸系统疾病,并可用于异物取出、肿瘤切除、支架置入、切片检查、止血和雷射治疗等操作。支气管镜有可重复使用和一次性两种类型,以满足医院、诊所、门诊手术中心和类似医疗机构的诊断和治疗需求。
2025年春季,美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要重新认证医疗设备,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供支气管镜市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的支气管镜细分市场、市场趋势和机会,以及您在支气管镜行业取得成功所需的数据。本支气管镜市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年的预测成长率为11.6%,较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国,导致来自德国和日本等主要地区的光纤影像处理束和关节控制机制的供应链中断,从而导致肺部手术延误和设备维护成本增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛。
呼吸系统疾病的日益普及预计将推动未来支气管镜市场的成长。呼吸系统疾病是指影响呼吸系统的疾病,例如气喘、慢性阻塞性肺病(COPD)、肺炎、支气管炎、囊肿纤维化、肺纤维化和肺癌。由于支气管镜检查是一种诊断和治疗工具,能够评估和治疗各种呼吸系统疾病,因此这些疾病的发生率上升可能会导致对支气管镜的需求增加。例如,根据澳洲政府机构澳洲健康与福利研究所 (AIHW) 2024 年 6 月发布的报告,到 2023 年,慢性阻塞性肺病 (COPD) 将占总疾病负担的 3.6%,占呼吸系统疾病负担的 50%。此外,据报道,2022 年 87% 的 COPD 患者将患有一种或多种合併症,其中最常见的是精神/行为问题(49%)、关节炎(45%)、气喘和背部问题(各 42%)。因此,呼吸系统疾病盛行率的上升预计将增强支气管镜市场。
预计未来对微创手术的需求将推动支气管镜市场的成长。微创手术 (MIP) 是透过体内小切口进行的外科手术。微创支气管镜检查具有多种优势,包括侵入性降低、患者偏好、诊断和治疗方法的进步、恢復时间更短以及併发症率更低。柔性支气管镜和视讯支气管镜等先进仪器的发展提高了这些手术的准确性和有效性。例如,2023 年 9 月,美国美容整形外科医师协会 (ISAPS) 报告称,2022 年整形外科医生执行的手术数量将增加 11.2%,全球整体外科手术超过 1490 万例,非外科手术超过 1880 万例。因此,对微创手术的不断增长的需求正在推动支气管镜市场的成长。
支气管镜市场的主要企业正在开发细直径支气管镜等创新产品,以提高患者舒适度、增强远端气道的可及性并优化微创手术中的诊断和治疗能力。细直径支气管镜采用窄型设计,方便进入小气道并提高患者在手术过程中的舒适度。例如,2024 年 5 月,日本医疗技术和光学公司奥林巴斯株式会社推出了与 EVIS X1 内视镜系统相容的支气管镜。 BF-H1100 和 BF-1TH1100 支气管镜具有高清影像和细直径,可改善远端气道的可及性。 BF-H1100 具有 2.2 毫米工作通道,吸力提高 11%,而 BF-1TH1100 具有 3.0 毫米工作通道,吸力提高 29%。两款型号均采用重新设计的影像感测器,以实现高清电视分辨率,并结合了 BAI-MAC、TXI、RDI 和 NBI 等先进成像技术,以提高支气管镜检查过程中的诊断准确性。
支气管镜市场的主要企业正致力于开发具有即时影像处理功能的先进机器人技术,以提高诊断准确性、减轻患者不适感并缩短肺部疾病诊疗过程中的恢復时间。具有即时成像功能的先进机器人技术包括利用即时成像技术即时引导精确操作和决策的机器人系统。例如,2024年9月,美国医疗保健供应商TidalHealth Nanticoke推出了一款基于Ion平台的先进机器人支气管镜系统,以增强肺部疾病的诊断和治疗。这项最尖端科技为微创肺组织切片检查提供了高清视觉化和精确度,使专家能够更有效地导航复杂的支气管通道。
2022年5月,总部位于爱尔兰的知名医疗设备公司Medtronic)完成了对Intersect ENT的收购,收购金额未揭露。此策略措施整合了Intersect ENT的创新鼻窦植入产品,包括PROPEL和SINUVA,显着扩展了Medtronic力在耳鼻喉(ENT)领域的产品组合。这些新增产品增强了Medtronic为慢性鼻窦炎(CRS)患者提供更全面护理的能力,并巩固了其在全球医疗技术市场的地位。 Intersect ENT是一家美国医疗设备製造商,专门开髮用于耳鼻喉(ENT)疾病的给药装置。
支气管镜市场的主要企业包括 Ambu A/S、波士顿科学公司、Cogentix Medical Inc.、Cook Medical LLC、富士胶片控股公司、Hoya Corporation、Karl Storz Endoscopy SE & Co.KG、奥林巴斯公司、PENTAX Medical、Richard Wolf GmbH、Teleflex Incorporchinated、EFpieER GmbH、Uptake Medical BV、Broncus Medical Inc.、Novatech SA、上海奥华光电内视镜有限公司、Rochling Group、Stryker Corporation、NeoScope Inc.、Bryan Corporation、CONMED Corporation、Laborie Medical Technologies Corp.、Envision Endoscopy Inc.、SonoScape Medical Corp.、Vertronon Inc. 和 Medtronic plc。
2024年,北美是支气管镜市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。支气管镜市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。
支气管镜市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
支气管镜市场包括光纤支气管镜和视讯支气管镜的销售。该市场的价值为“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
A bronchoscope is a vital medical instrument employed to visually examine the lungs and airways. It comprises a flexible or rigid tube equipped with a camera and light source at its tip, enabling physicians to observe the trachea, bronchi, and bronchioles. This device serves both diagnostic and therapeutic purposes, facilitating procedures such as tissue biopsy, foreign object removal, and various airway medical interventions.
Two primary variants of bronchoscopes exist, rigid and flexible. Rigid bronchoscopes, crafted from metal and composed of handles, tubes, and sheaths, find application in diagnosing and treating respiratory conditions. They are instrumental in procedures including foreign body extraction, tumor excision, stent insertion, biopsy, hemostasis, and laser therapy. Bronchoscopes come in reusable and disposable forms, catering to diagnostic and treatment needs across hospital settings, clinics, ambulatory surgical centers, and similar medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The bronchoscope market research report is one of a series of new reports from The Business Research Company that provides bronchoscope market statistics, including bronchoscope industry global market size, regional shares, competitors with a bronchoscope market share, detailed bronchoscope market segments, market trends and opportunities, and any further data you may need to thrive in the bronchoscope industry. This bronchoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bronchoscope market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.2 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing awareness and acceptance, medical training and education, clinical applications and endobronchial interventions, demand for minimally invasive techniques, aging population dynamics.
The bronchoscope market size is expected to see rapid growth in the next few years. It will grow to $4.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising respiratory disorders, growing aging population, demand for minimally invasive procedures, advancements in robotics, focus on early diagnosis. Major trends in the forecast period include miniaturization and portability, focus on patient safety and comfort, augmented reality (AR) and navigation systems, telemedicine and remote guidance, disposable bronchoscopes.
The forecast of 11.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for fiberoptic imaging bundles and articulating control mechanisms, sourced from key regions such as Germany and Japan, which could lead to delayed pulmonary procedures and increased equipment maintenance costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of respiratory tract disorders is expected to drive the growth of the bronchoscope market in the future. Respiratory tract disorders are medical conditions that impact the respiratory system, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, cystic fibrosis, pulmonary fibrosis, and lung cancer. Bronchoscopy serves as a diagnostic and therapeutic tool that can evaluate and treat various respiratory tract disorders; therefore, the rise in these conditions is likely to lead to increased demand for bronchoscopes. For instance, in June 2024, a report from the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, stated that in 2023, COPD accounted for 3.6% of the total disease burden and 50% of the burden from respiratory conditions. Additionally, it was reported that 87% of COPD patients in 2022 had one or more comorbidities, with the most prevalent being mental and behavioral conditions (49%), arthritis (45%), and asthma and back problems (42% each). Therefore, the rise in the prevalence of respiratory tract disorders is anticipated to enhance the bronchoscope market.
The growing demand for minimally invasive procedures is expected to drive the growth of the bronchoscope market in the future. Minimally invasive procedures (MIPs) are surgical interventions conducted through small incisions in the body. Minimally invasive bronchoscopy provides several advantages, including reduced invasiveness, patient preference, advancements in diagnostics and therapeutics, faster recovery times, and lower complication rates. The development of advanced instruments, such as flexible and video bronchoscopes, enhances the precision and effectiveness of these procedures. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for board-certified aesthetic plastic surgeons, reported an 11.2% increase in procedures performed by plastic surgeons in 2022, with over 14.9 million surgical and 18.8 million non-surgical procedures carried out globally. Thus, the rising demand for minimally invasive procedures is driving the growth of the bronchoscope market.
Major companies in the bronchoscope market are developing innovative products, such as slim outer diameter bronchoscopes, to improve patient comfort, enhance access to distal airways, and optimize diagnostic and therapeutic capabilities in minimally invasive procedures. Slim bronchoscopes feature a narrow design that facilitates easier access to smaller airways and increases patient comfort during procedures. For example, in May 2024, Olympus Corporation, a Japan-based medical technology and optics company, launched bronchoscopes compatible with the EVIS X1 endoscopy system. The BF-H1100 and BF-1TH1100 bronchoscopes are equipped with high-definition imaging and a slim outer diameter to improve access to distal airways. The BF-H1100 includes a 2.2mm working channel, providing an 11% increase in suction, while the BF-1TH1100 has a 3.0mm working channel with a 29% suction increase. Both models feature a redesigned image sensor for HDTV resolution and incorporate advanced imaging technologies, such as BAI-MAC, TXI, RDI, and NBI, which enhance diagnostic accuracy in bronchoscopic procedures.
Major companies in the bronchoscope market are concentrating on developing advanced robotics with real-time imaging to improve diagnostic accuracy, reduce patient discomfort, and shorten recovery times during lung disease diagnosis and treatment. Advanced robotics with real-time imaging involves robotic systems that utilize live imaging technologies to guide precise actions and decision-making in real-time. For example, in September 2024, TidalHealth Nanticoke, a US-based healthcare organization, launched an advanced robotic bronchoscopy system using the Ion platform to enhance the diagnosis and treatment of lung diseases. This cutting-edge technology offers high-definition visualization and precision for less invasive lung tissue biopsies, allowing specialists to navigate complex bronchial passages more effectively.
In May 2022, Medtronic plc, an esteemed medical devices company based in Ireland, completed the acquisition of Intersect ENT for an undisclosed sum. This strategic move significantly broadened Medtronic's portfolio within the ear, nose, and throat (ENT) segment by integrating innovative sinus implant products such as PROPEL and SINUVA from Intersect ENT. These additions enhance Medtronic's capacity to provide a more comprehensive range of care for individuals coping with chronic rhinosinusitis (CRS), fortifying its foothold in the global healthcare technology market. Intersect ENT, a US-based medical device manufacturer, specializes in developing drug-delivery devices tailored for ear, nose, and throat (ENT) conditions.
Major companies operating in the bronchoscope market include Ambu A/S, Boston Scientific Corporation, Cogentix Medical Inc., Cook Medical LLC, Fujifilm Holdings Corporation, Hoya Corporation, Karl Storz Endoscopy SE & Co. KG, Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Teleflex Incorporated, EFER Endoscopy Srl, Lymol Medical Corporation, Schindler Endoskopie Technology GmbH, Scholly Fiberoptic GmbH, Uptake Medical B.V., Broncus Medical Inc., Novatech SA, Shanghai AoHua Photoelectricity Endoscope Co. Ltd., Rochling Group, Stryker Corporation, NeoScope Inc., Bryan Corporation, CONMED Corporation, Laborie Medical Technologies Corp., Envision Endoscopy Inc., SonoScape Medical Corp., Verathon Inc., Medtronic plc
North America was the largest region in the bronchoscope market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the bronchoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bronchoscope market consists of sales of fiber optic bronchoscopes and video bronchoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bronchoscope Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bronchoscope market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bronchoscope ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bronchoscope market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.